Greetings
CEO Greetings
STEMON is a specialized
cell reprogramming company
that has developed an Entr®
original technology of a new paradigm.
STEMON Inc. is a specialized cell reprogramming company that developed
Entr® (ultrasound-directed permeation of Environmental transition-guided cellular reprogramming),
an original technology for cell reprogramming with only ultrasound
and environmental factors used without genes used, unlike conventional methods.
An innovative company that develops treatments
STEMON Inc. recently developed UltraRepro®, the world's first equipment for automating Entr® core technology,
and suggested alternatives to overcome a lot of problems such as the low efficiency,
stability, and immune rejection of conventional cell therapies.
In addition, STEMON Inc. succeeded in mass production of Reprosome, various customized exosomes induced from dermal fibroblasts using the
Entr® automation system, and is currently promoting the development of treatments for various intractable diseases, including immune and respiratory diseases. Accordingly, this company will develop into an innovative company that develops cell therapy products in the future.
Game Changer
of Future Cell Therapy
In a new era in which many fields of daily life have developed rapidly, STEMON Inc. will grow into a GAME CHANGER company that prepares the future for human health and longevity based on deep sympathy for human society to accelerate the popularization of autologous cell therapy in the future, ultimately realizing the happiness of all mankind.
CEO Soonhag Kim.
